 Ritsuko Iwanaga
Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| E2F1 Transcription Factor | 12 | 2025 | 64 | 1.780 |
Why?
| | Gene Expression Regulation, Neoplastic | 7 | 2025 | 1396 | 0.770 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 18 | 0.670 |
Why?
| | Tumor Microenvironment | 1 | 2024 | 676 | 0.660 |
Why?
| | Melanocytes | 1 | 2020 | 65 | 0.650 |
Why?
| | Zebrafish Proteins | 1 | 2020 | 288 | 0.530 |
Why?
| | Ovarian Neoplasms | 4 | 2024 | 565 | 0.490 |
Why?
| | Ligaments | 1 | 2016 | 60 | 0.480 |
Why?
| | Zebrafish | 1 | 2020 | 499 | 0.480 |
Why?
| | E2F Transcription Factors | 6 | 2023 | 60 | 0.470 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 860 | 0.470 |
Why?
| | Pelvis | 1 | 2016 | 106 | 0.460 |
Why?
| | Uterus | 1 | 2016 | 215 | 0.450 |
Why?
| | Gene Products, tax | 2 | 2024 | 13 | 0.450 |
Why?
| | Human T-lymphotropic virus 1 | 2 | 2024 | 28 | 0.440 |
Why?
| | DEAD-box RNA Helicases | 2 | 2025 | 76 | 0.440 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2024 | 528 | 0.440 |
Why?
| | Models, Animal | 1 | 2016 | 384 | 0.440 |
Why?
| | Vagina | 1 | 2016 | 187 | 0.430 |
Why?
| | Homeodomain Proteins | 3 | 2012 | 506 | 0.420 |
Why?
| | Polycomb Repressive Complex 1 | 2 | 2024 | 50 | 0.410 |
Why?
| | Cell Line, Tumor | 13 | 2025 | 3415 | 0.410 |
Why?
| | Melanoma | 1 | 2020 | 760 | 0.400 |
Why?
| | Promoter Regions, Genetic | 12 | 2025 | 1251 | 0.400 |
Why?
| | Histone-Lysine N-Methyltransferase | 2 | 2024 | 136 | 0.390 |
Why?
| | Transforming Growth Factor beta | 2 | 2012 | 483 | 0.380 |
Why?
| | Gene Expression Regulation | 6 | 2023 | 2607 | 0.370 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 171 | 0.360 |
Why?
| | Neoplastic Stem Cells | 3 | 2014 | 399 | 0.320 |
Why?
| | Transcriptional Activation | 4 | 2024 | 378 | 0.310 |
Why?
| | Retinoblastoma Protein | 4 | 2025 | 57 | 0.300 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 2 | 2024 | 115 | 0.250 |
Why?
| | Genes, Tumor Suppressor | 4 | 2023 | 86 | 0.240 |
Why?
| | Breast Neoplasms | 3 | 2014 | 2253 | 0.240 |
Why?
| | Growth Substances | 1 | 2004 | 147 | 0.220 |
Why?
| | Cyclin-Dependent Kinases | 2 | 2024 | 132 | 0.220 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2024 | 27 | 0.220 |
Why?
| | BRCA2 Protein | 1 | 2024 | 63 | 0.220 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 2024 | 77 | 0.210 |
Why?
| | Fibroblasts | 5 | 2018 | 996 | 0.210 |
Why?
| | Transcription Factor DP1 | 2 | 2023 | 21 | 0.200 |
Why?
| | DNA Repair | 1 | 2004 | 231 | 0.200 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2024 | 801 | 0.190 |
Why?
| | Animals | 10 | 2024 | 36951 | 0.180 |
Why?
| | Mice | 7 | 2024 | 17794 | 0.180 |
Why?
| | Tumor Suppressor Proteins | 2 | 2014 | 327 | 0.170 |
Why?
| | Tumor Suppressor Protein p14ARF | 2 | 2014 | 7 | 0.170 |
Why?
| | Signal Transduction | 3 | 2016 | 5081 | 0.170 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2016 | 15 | 0.160 |
Why?
| | Bcl-2-Like Protein 11 | 2 | 2016 | 38 | 0.160 |
Why?
| | Prognosis | 3 | 2020 | 4039 | 0.160 |
Why?
| | Apoptosis | 8 | 2024 | 2553 | 0.150 |
Why?
| | Neoplasms | 3 | 2023 | 2673 | 0.150 |
Why?
| | Humans | 25 | 2025 | 137782 | 0.150 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 903 | 0.140 |
Why?
| | Proto-Oncogene Proteins | 2 | 2015 | 648 | 0.140 |
Why?
| | Genes, p16 | 1 | 2016 | 20 | 0.130 |
Why?
| | Macrophages | 1 | 2024 | 1549 | 0.130 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 121 | 0.130 |
Why?
| | Connective Tissue | 1 | 2016 | 36 | 0.130 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 617 | 0.130 |
Why?
| | Pelvic Organ Prolapse | 1 | 2016 | 51 | 0.120 |
Why?
| | DNA-Binding Proteins | 4 | 2018 | 1502 | 0.120 |
Why?
| | Survival Rate | 1 | 2020 | 1973 | 0.120 |
Why?
| | Muscle, Smooth | 1 | 2016 | 155 | 0.120 |
Why?
| | Vascular Endothelial Growth Factor C | 1 | 2014 | 17 | 0.110 |
Why?
| | Disease Progression | 2 | 2020 | 2760 | 0.110 |
Why?
| | Transcription Factors, TFII | 2 | 2024 | 41 | 0.110 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2015 | 188 | 0.110 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 366 | 0.110 |
Why?
| | Nuclear Proteins | 2 | 2012 | 712 | 0.110 |
Why?
| | Neoplasms, Experimental | 1 | 2014 | 176 | 0.100 |
Why?
| | Cells, Cultured | 1 | 2020 | 4193 | 0.100 |
Why?
| | Cell Differentiation | 1 | 2020 | 1991 | 0.100 |
Why?
| | Superoxide Dismutase | 1 | 2014 | 346 | 0.100 |
Why?
| | Antibodies, Neoplasm | 1 | 2012 | 34 | 0.090 |
Why?
| | Heterografts | 1 | 2012 | 138 | 0.090 |
Why?
| | Cell Line | 4 | 2018 | 2847 | 0.090 |
Why?
| | Female | 8 | 2024 | 73465 | 0.090 |
Why?
| | Cluster Analysis | 1 | 2012 | 501 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 1 | 2016 | 2487 | 0.080 |
Why?
| | Membrane Proteins | 1 | 2015 | 1164 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 75 | 0.070 |
Why?
| | Response Elements | 2 | 2008 | 91 | 0.070 |
Why?
| | Cell Proliferation | 3 | 2024 | 2475 | 0.070 |
Why?
| | Protein Binding | 4 | 2024 | 2224 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2024 | 4295 | 0.070 |
Why?
| | Rats | 1 | 2016 | 5648 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 69 | 0.060 |
Why?
| | Mice, Inbred C57BL | 1 | 2016 | 5764 | 0.060 |
Why?
| | MutS Homolog 3 Protein | 1 | 2004 | 2 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2012 | 1775 | 0.060 |
Why?
| | Acid Anhydride Hydrolases | 1 | 2004 | 6 | 0.060 |
Why?
| | MutL Protein Homolog 1 | 1 | 2004 | 12 | 0.060 |
Why?
| | MutS Homolog 2 Protein | 1 | 2004 | 15 | 0.060 |
Why?
| | Culture Media, Serum-Free | 1 | 2004 | 48 | 0.060 |
Why?
| | Rad51 Recombinase | 1 | 2004 | 15 | 0.060 |
Why?
| | DNA Repair Enzymes | 1 | 2004 | 28 | 0.060 |
Why?
| | Cyclin D2 | 1 | 2024 | 5 | 0.060 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2024 | 39 | 0.050 |
Why?
| | Jurkat Cells | 1 | 2024 | 134 | 0.050 |
Why?
| | Histocompatibility Antigens | 1 | 2024 | 105 | 0.050 |
Why?
| | Base Sequence | 2 | 2005 | 2181 | 0.050 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2024 | 81 | 0.050 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2005 | 283 | 0.050 |
Why?
| | E2F3 Transcription Factor | 1 | 2023 | 10 | 0.050 |
Why?
| | Transcription Factors | 2 | 2018 | 1719 | 0.050 |
Why?
| | Polycomb-Group Proteins | 1 | 2023 | 28 | 0.050 |
Why?
| | Molecular Sequence Data | 2 | 2005 | 2900 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2005 | 455 | 0.050 |
Why?
| | Cell Death | 1 | 2024 | 374 | 0.050 |
Why?
| | Protein Domains | 1 | 2024 | 289 | 0.050 |
Why?
| | DNA Replication | 1 | 2004 | 238 | 0.050 |
Why?
| | Cell Division | 1 | 2004 | 794 | 0.050 |
Why?
| | Telomerase | 1 | 2005 | 250 | 0.050 |
Why?
| | Neoplasm Transplantation | 2 | 2014 | 257 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2004 | 430 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2004 | 434 | 0.040 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2526 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2024 | 872 | 0.040 |
Why?
| | Lysine | 1 | 2023 | 294 | 0.040 |
Why?
| | Serum | 2 | 2012 | 59 | 0.040 |
Why?
| | Transplantation, Heterologous | 2 | 2012 | 194 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2004 | 771 | 0.040 |
Why?
| | NF-kappa B | 1 | 2024 | 691 | 0.040 |
Why?
| | Mice, SCID | 2 | 2012 | 367 | 0.040 |
Why?
| | Phosphorylation | 1 | 2024 | 1759 | 0.040 |
Why?
| | Adenovirus E1A Proteins | 2 | 2012 | 12 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 660 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2005 | 1457 | 0.040 |
Why?
| | Histones | 1 | 2024 | 636 | 0.040 |
Why?
| | ADP-Ribosylation Factors | 1 | 2018 | 18 | 0.040 |
Why?
| | Dimerization | 1 | 2018 | 199 | 0.040 |
Why?
| | Peptides | 1 | 2023 | 985 | 0.030 |
Why?
| | Ectopic Gene Expression | 1 | 2016 | 4 | 0.030 |
Why?
| | RNA Interference | 1 | 2018 | 469 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2005 | 1998 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 622 | 0.030 |
Why?
| | Claudins | 1 | 2014 | 25 | 0.030 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2014 | 7 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2014 | 100 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 327 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2014 | 686 | 0.020 |
Why?
| | Tumor Protein p73 | 1 | 2012 | 14 | 0.020 |
Why?
| | Genetic Therapy | 1 | 2014 | 297 | 0.020 |
Why?
| | Etoposide | 1 | 2012 | 158 | 0.020 |
Why?
| | Culture Media | 1 | 2012 | 165 | 0.020 |
Why?
| | Antibody Specificity | 1 | 2012 | 189 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1272 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2014 | 623 | 0.020 |
Why?
| | Adenoviridae | 1 | 2012 | 193 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2012 | 375 | 0.020 |
Why?
| | Point Mutation | 1 | 2012 | 235 | 0.020 |
Why?
| | Antioxidants | 1 | 2014 | 585 | 0.020 |
Why?
| | RNA, Messenger | 2 | 2012 | 2834 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 945 | 0.020 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2009 | 68 | 0.020 |
Why?
| | E2F4 Transcription Factor | 1 | 2008 | 8 | 0.020 |
Why?
| | Mesoderm | 1 | 2009 | 144 | 0.020 |
Why?
| | Epithelium | 1 | 2009 | 313 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2012 | 1178 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2014 | 1317 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2009 | 601 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1738 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 658 | 0.020 |
Why?
| | Cyclin D | 1 | 2005 | 9 | 0.020 |
Why?
| | Cyclin D1 | 1 | 2005 | 68 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2005 | 86 | 0.010 |
Why?
| | Cyclins | 1 | 2005 | 91 | 0.010 |
Why?
| | Gene Silencing | 1 | 2005 | 195 | 0.010 |
Why?
| | Gene Expression | 1 | 2009 | 1502 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2009 | 2167 | 0.010 |
Why?
| | Cell Cycle | 1 | 2005 | 601 | 0.010 |
Why?
| | Binding Sites | 1 | 2005 | 1303 | 0.010 |
Why?
| | Up-Regulation | 1 | 2005 | 843 | 0.010 |
Why?
| | Models, Biological | 1 | 2005 | 1783 | 0.010 |
Why?
| | Mutation | 1 | 2005 | 3959 | 0.010 |
Why?
| | Male | 1 | 2009 | 67906 | 0.000 |
Why?
|
|
Iwanaga's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|